Indeed, Ikaros proteins act as tumor suppressors in different types of leukemia (where their function is inhibited), whereas they are overexpressed in other malignancies (where they are necessary) to sustain the survival and proliferation of cancer cells, such as in Multiple Myeloma (MM) [7,8]. This evidence concerns the gene IKZF1 and Miyoshi myopathy.